Companies / Mexico
Pfizer Launches Exubera Inhaled Insulin
July 2007 | Product LaunchUS pharmaceutical giant Pfizer has launched its Exubera inhaled insulin product in Mexico, following earlier launches in the US, Brazil and European Union (EU). Diabetes is one of the leading causes of death in Mexico, with estimates of the number of sufferers starting at 6.5mn, with at least 1mn as yet undiagnosed sufferers. The Mexican launch will be a key test for the manufacturer's potential blockbuster, following reports of slow sales in the US since its launch there in
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
